SCHEMBL3676915

SCHEMBL3676915

CCc1c(N)c2ccc(OC)c(OCC3CC3)c2oc1=O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 12/20 0.47
HPGD P15428 6/20 0.47
KDM4E B2RXH2 10/20 0.43
TSHR P16473 4/20 0.43
HSD17B10 Q99714 4/20 0.43
MIF P14174 1/20 0.42
POLB P06746 2/20 0.42
HTT P42858 2/20 0.42
GAA P10253 1/20 0.42
CNR2 P34972 3/20 0.41
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
NPSR1 Q6W5P4 1/20 0.40
SMN1; SMN2 Q16637 2/20 0.38
LMNA P02545 1/20 0.38
PLA2G1B P04054 1/20 0.38
ATG4B Q9Y4P1 1/20 0.38
PDE4D Q08499 1/20 0.37
DRD2 P14416 1/20 0.37
DRD4 P21917 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3677927 0.78 PDE4B (0.49) PDE4D
SCHEMBL3683982 0.74 MCL1 (0.45) ALDH1A1HPGDKDM4ETSHRHSD17B10
SCHEMBL730921 0.67 NQO2 (0.49) ALDH1A1HPGDKDM4EHSD17B10GAA
SCHEMBL3674037 0.66 ALPL (0.51) ALDH1A1HPGDKDM4ETSHRHSD17B10
SCHEMBL3679983 0.66 PDE4B (0.52) POLBMEN1KMT2APDE4D
SCHEMBL3679926 0.66 PDE4B (0.48) ALDH1A1HPGDKDM4ETSHRHSD17B10
SCHEMBL729280 0.65 PDE4D (0.49) ALDH1A1KDM4ETSHRHSD17B10POLB
SCHEMBL3674317 0.65 PDE4B (0.73) PDE4D
SCHEMBL2587027 0.64 SMN1; SMN2 (0.57) ALDH1A1TSHRPOLBMEN1KMT2A
SCHEMBL16011771 0.64 SMN1; SMN2 (0.44) ALDH1A1KDM4EPOLBMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7745646-B2 Bicyclic heteroaryl inhibitors of PDE4 KALYPSYS, INC. (US) 2010-06-29 US disclosed
US-20080027112-A1 BICYCLIC HETEROARYL INHIBITORS OF PDE4 Govek, Steven (US) 2008-01-31 US disclosed
WO-2008006051-A2 BICYCLIC HETEROARYL INHIBITORS OF PDE4 GOVEK STEVEN P (US) 2008-01-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080027112-A1 BICYCLIC HETEROARYL INHIBITORS OF PDE4 PDE4A, PDE4B, PDE4C ALDH1A1 890/4885HPGD 114/4885KDM4E 1489/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.